Bernard Masquelier
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.
Journal: The Journal of antimicrobial chemotherapy
Published: October 23, 2014
HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.
Journal: PloS one
Published: July 24, 2014
Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.
Journal: PloS one
Published: October 07, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
Journal: The Journal of antimicrobial chemotherapy
Published: June 27, 2013
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
Journal: The Journal of antimicrobial chemotherapy
Published: February 14, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.
Journal: International journal of antimicrobial agents
Published: January 20, 2013
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.
Journal: The Journal of infectious diseases
Published: December 11, 2012
Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
Journal: PloS one
Published: October 22, 2012
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
Journal: The Journal of antimicrobial chemotherapy
Published: June 27, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.
Journal: PloS one
Published: March 16, 2012
Molecular characterization of non-B HIV type 1 isolates from patients of a department of infectious diseases, University Hospital of Bordeaux, France, 1989-2009.
Journal: AIDS research and human retroviruses
Published: December 02, 2011
Last Updated: 09/26/2026